Revenue growth has decelerated from 11.9% in 2024Q3 to -0.5% in 2026Q3 even as the combined ratio improved to 80.0% from 94.2%, suggesting reported earnings increasingly depend on underwriting margin expansion rather than top-line momentum.
The Travelers Companies, Inc. (TRV) annual income statement — 30-year revenue, gross profit & net income history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Revenue | 48.92B | 48.83B | 46.43B | 41.37B | 36.9B | 34.82B | 31.98B | 31.58B | 30.28B | 28.9B | 27.63B | 26.82B | 27.17B | 26.19B | 25.74B | 25.45B | 25.11B | 24.68B | 24.48B | 26.02B | 25.09B | 24.36B | 22.54B | 15.14B | 14.27B | 9.03B | 7.95B | 7.15B | 9.11B | 9.62B | 9.23B |
| Revenue Growth % | 1.06% | 5.17% | 12.22% | 12.13% | 5.97% | 8.86% | 1.27% | 4.29% | 4.77% | 4.62% | 3.02% | -1.32% | 3.75% | 1.75% | 1.16% | 1.33% | 1.75% | 0.83% | -5.92% | 3.69% | 2.98% | 8.08% | 48.91% | 6.09% | 57.99% | 13.67% | 11.15% | -21.51% | -5.35% | 4.24% | 70.65% |
| Medical Costs & Claims | 31.87B | 34.49B | 34.03B | 32.44B | 28.37B | 25.34B | 23.9B | 23.73B | 22.67B | 21.63B | 19.05B | 17.61B | 17.75B | 17.13B | 18.59B | 20.15B | 17.01B | 16.22B | 16.87B | 16.1B | 15.58B | 18.18B | 18.42B | 11.1B | 12.95B | 9.18B | 5.31B | 5.04B | 7.53B | 5.05B | 5B |
| Medical Cost Ratio % | 65.14% | 70.63% | 73.3% | 78.41% | 76.89% | 72.79% | 74.72% | 75.15% | 74.87% | 74.85% | 68.98% | 65.66% | 65.33% | 65.4% | 72.21% | 79.2% | 67.74% | 65.73% | 68.93% | 61.89% | 62.11% | 74.61% | 81.69% | 73.33% | 90.74% | 101.65% | 66.81% | 70.51% | 82.67% | 52.52% | 54.17% |
| Gross Profit | 17.05B | 14.34B | 12.4B | 8.93B | 8.53B | 9.47B | 8.09B | 7.85B | 7.61B | 7.27B | 8.57B | 9.21B | 9.42B | 9.06B | 7.15B | 5.29B | 8.1B | 8.46B | 7.6B | 9.91B | 9.51B | 6.19B | 4.13B | 4.04B | 1.32B | -149M | 2.64B | 2.11B | 1.58B | 4.57B | 4.23B |
| Gross Margin % | 34.86% | 29.37% | 26.7% | 21.59% | 23.11% | 27.21% | 25.28% | 24.85% | 25.13% | 25.15% | 31.02% | 34.34% | 34.67% | 34.6% | 27.79% | 20.8% | 32.26% | 34.27% | 31.07% | 38.11% | 37.89% | 25.39% | 18.31% | 26.67% | 9.26% | -1.65% | 33.19% | 29.49% | 17.33% | 47.48% | 45.83% |
| Gross Profit Growth % | - | 15.69% | 38.78% | 4.75% | -10.01% | 17.19% | 3.03% | 3.11% | 4.69% | -15.18% | -6.92% | -2.28% | 3.96% | 26.68% | 35.13% | -34.64% | -4.24% | 11.24% | -23.3% | 4.28% | 53.69% | 49.89% | 2.23% | 205.6% | 986.58% | -105.65% | 25.09% | 33.55% | -65.45% | 8% | 150.56% |
| Operating Expenses | 6.46B | 6.54B | 6.22B | 5.56B | 5.17B | 5.02B | 4.85B | 4.71B | 4.65B | 4.54B | 4.52B | 4.47B | 4.33B | 4.12B | 3.99B | 3.94B | 3.79B | 3.75B | 3.89B | 3.7B | 3.78B | 3.52B | 3.18B | 1.81B | 1.58B | 1.28B | 1.24B | 1.16B | 1.62B | -2.14B | -2.23B |
| OpEx / Revenue % | 13.21% | 13.4% | 13.39% | 13.44% | 14.02% | 14.41% | 15.16% | 14.91% | 15.35% | 15.7% | 16.35% | 16.66% | 15.95% | 15.72% | 15.49% | 15.49% | 15.11% | 15.19% | 15.88% | 14.21% | 15.07% | 14.43% | 14.11% | 11.94% | 11.08% | 14.19% | 15.55% | 16.18% | 17.84% | -22.21% | -24.12% |
| Depreciation & Amortization | 529M | 680M | 715M | 722M | 826M | 870M | 789M | 763M | 803M | 813M | 826M | 818M | 864M | 867M | 827M | 802M | 812M | 797M | 821M | 811M | 808M | 691M | 522M | 85M | 42M | 180M | 105M | 118M | 132.9M | 108M | 98M |
| Combined Ratio % | 78.35% | 84.03% | 86.69% | 91.85% | 90.91% | 87.2% | 89.88% | 90.06% | 90.22% | 90.55% | 85.33% | 82.32% | 81.27% | 81.12% | 87.7% | 94.69% | 82.85% | 80.91% | 84.82% | 76.11% | 77.18% | 89.04% | 95.8% | 85.28% | 101.82% | 115.84% | 82.37% | 86.7% | 100.51% | 30.31% | 30.05% |
| Operating Income | 10.59B | 7.8B | 6.18B | 3.37B | 3.35B | 4.46B | 3.24B | 3.14B | 2.96B | 2.73B | 4.05B | 4.74B | 5.09B | 4.95B | 3.17B | 1.35B | 4.31B | 4.71B | 3.72B | 6.22B | 5.72B | 2.67B | 946M | 2.23B | -260M | -1.43B | 1.4B | 951M | -46.29M | 6.71B | 6.46B |
| Operating Margin % | 21.65% | 15.97% | 13.31% | 8.15% | 9.09% | 12.8% | 10.12% | 9.94% | 9.78% | 9.45% | 14.67% | 17.68% | 18.73% | 18.88% | 12.3% | 5.31% | 17.15% | 19.09% | 15.18% | 23.89% | 22.82% | 10.96% | 4.2% | 14.72% | -1.82% | -15.84% | 17.63% | 13.3% | -0.51% | 69.69% | 69.95% |
| Operating Income Growth % | - | 26.15% | 83.33% | 0.51% | -24.76% | 37.72% | 3.15% | 5.98% | 8.46% | -32.64% | -14.49% | -6.86% | 2.91% | 56.19% | 134.17% | -68.6% | -8.6% | 26.78% | -40.22% | 8.58% | 114.34% | 182.35% | -57.56% | 957.31% | 81.83% | -202.14% | 47.32% | 2154.57% | -100.69% | 3.85% | 884.01% |
| EBITDA | 11.12B | 8.48B | 6.89B | 4.09B | 4.18B | 5.33B | 4.03B | 3.9B | 3.76B | 3.54B | 4.88B | 5.56B | 5.95B | 5.81B | 3.99B | 2.15B | 5.12B | 5.51B | 4.54B | 7.03B | 6.53B | 3.36B | 1.47B | 2.31B | -218M | -1.25B | 1.51B | 1.07B | 86.61M | 6.81B | 6.56B |
| EBITDA Margin % | 22.73% | 17.36% | 14.85% | 9.89% | 11.33% | 15.3% | 12.59% | 12.35% | 12.43% | 12.26% | 17.66% | 20.73% | 21.91% | 22.19% | 15.51% | 8.46% | 20.38% | 22.32% | 18.54% | 27.01% | 26.04% | 13.8% | 6.51% | 15.29% | -1.53% | -13.85% | 18.95% | 14.95% | 0.95% | 70.81% | 71.01% |
| Interest Expense | 463M | 425M | 392M | 376M | 351M | 340M | 339M | 344M | 352M | 369M | 363M | 373M | 369M | 361M | 378M | 386M | 388M | 382M | 370M | 346M | 324M | 286M | 236M | 167M | 157M | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Operating Income | -232M | -425M | -392M | -376M | -351M | -340M | -339M | -344M | -352M | -369M | -363M | -373M | -369M | -361M | -378M | -386M | -388M | -382M | -370M | -346M | -324M | -286M | -236M | -167M | -157M | 0 | 0 | 0 | 0 | 0 | 0 |
| Pretax Income | 10.36B | 7.8B | 6.18B | 3.37B | 3.35B | 4.46B | 3.24B | 3.14B | 2.96B | 2.73B | 4.05B | 4.74B | 5.09B | 4.95B | 3.17B | 1.35B | 4.31B | 4.71B | 3.72B | 6.22B | 5.72B | 2.67B | 946M | 2.23B | -260M | -1.43B | 1.4B | 951M | -46.29M | 1.34B | 991.1M |
| Pretax Margin % | 21.17% | 15.97% | 13.31% | 8.15% | 9.09% | 12.8% | 10.12% | 9.94% | 9.78% | 9.45% | 14.67% | 17.68% | 18.73% | 18.88% | 12.3% | 5.31% | 17.15% | 19.09% | 15.18% | 23.89% | 22.82% | 10.96% | 4.2% | 14.72% | -1.82% | -15.84% | 17.63% | 13.3% | -0.51% | 13.88% | 10.74% |
| Income Tax | 2.03B | 1.51B | 1.18B | 380M | 512M | 796M | 540M | 516M | 438M | 674M | 1.04B | 1.3B | 1.4B | 1.27B | 693M | -74M | 1.09B | 1.09B | 792M | 1.61B | 1.52B | 610M | 69M | 537M | -477M | -422M | 431M | 219M | -135.63M | 338.7M | 150.6M |
| Effective Tax Rate % | 19.56% | 19.34% | 19.11% | 11.27% | 15.27% | 17.86% | 16.68% | 16.44% | 14.79% | 24.69% | 25.64% | 27.45% | 27.45% | 25.72% | 21.89% | -5.47% | 25.31% | 23.12% | 21.31% | 25.98% | 26.5% | 22.84% | 7.29% | 24.09% | 183.46% | 29.49% | 30.76% | 23.03% | 293.03% | 25.36% | 15.2% |
| Net Income | 8.33B | 6.29B | 5B | 2.99B | 2.84B | 3.66B | 2.7B | 2.62B | 2.52B | 2.06B | 3.01B | 3.44B | 3.69B | 3.67B | 2.47B | 1.43B | 3.22B | 3.62B | 2.92B | 4.6B | 4.21B | 1.62B | 955M | 1.7B | -27M | -1.09B | 993M | 834M | 89.35M | 929.2M | 732.7M |
| Net Margin % | 17.03% | 12.88% | 10.77% | 7.23% | 7.7% | 10.52% | 8.43% | 8.3% | 8.33% | 7.11% | 10.91% | 12.82% | 13.59% | 14.02% | 9.61% | 5.6% | 12.81% | 14.68% | 11.95% | 17.68% | 16.77% | 6.66% | 4.24% | 11.2% | -0.19% | -12.05% | 12.5% | 11.67% | 0.98% | 9.66% | 7.94% |
| Net Income Growth % | 41.85% | 25.79% | 67.13% | 5.24% | -22.39% | 35.78% | 2.86% | 3.92% | 22.71% | -31.79% | -12.36% | -6.85% | 0.52% | 48.52% | 73.42% | -55.66% | -11.21% | 23.87% | -36.45% | 9.34% | 159.43% | 69.84% | -43.69% | 6381.48% | 97.52% | -209.57% | 19.06% | 833.43% | -90.38% | 26.82% | 40.58% |
| EPS (Diluted) | 39.56 | 27.43 | 21.47 | 12.79 | 11.77 | 14.49 | 10.52 | 9.92 | 9.35 | 7.33 | 10.28 | 10.88 | 10.70 | 9.74 | 6.30 | 3.36 | 6.62 | 6.33 | 4.81 | 6.85 | 5.91 | 2.33 | 1.53 | 3.80 | 0.93 | -5.13 | 4.24 | 3.41 | 0.32 | 3.97 | 2.84 |
| EPS Growth % | 49.98% | 27.76% | 67.87% | 8.67% | -18.77% | 37.74% | 6.05% | 6.1% | 27.56% | -28.7% | -5.51% | 1.68% | 9.86% | 54.6% | 87.5% | -49.24% | 4.58% | 31.6% | -29.78% | 15.91% | 153.65% | 52.29% | -59.74% | 308.6% | 118.13% | -220.99% | 24.34% | 965.63% | -91.94% | 39.79% | 0% |
| EPS (Basic) | - | 27.84 | 21.76 | 12.93 | 11.91 | 14.63 | 10.56 | 10.01 | 9.44 | 7.39 | 10.39 | 10.99 | 10.82 | 9.84 | 6.35 | 3.40 | 6.69 | 6.38 | 4.87 | 7.00 | 6.12 | 2.39 | 1.56 | 3.91 | 0.97 | -5.13 | 4.50 | 3.61 | 0.33 | 3.97 | 3.01 |
| Diluted Shares Outstanding | 210.6M | 227.6M | 231.1M | 232.2M | 239.7M | 250.8M | 254.6M | 262.3M | 269.8M | 278.6M | 291M | 313.9M | 342.5M | 374.3M | 389.8M | 420.5M | 482.5M | 577.5M | 604.3M | 668.6M | 716.7M | 712.8M | 628.3M | 453.3M | 233.5M | 212M | 233M | 246M | 252.65M | 176.8M | 188.25M |
Quick answers to the most common questions about buying TRV stock.
For fiscal year 2025, The Travelers Companies, Inc. (TRV) reported total revenue of $48.83B. This represents a 428.9% increase compared to $9.23B in 1996.
The Travelers Companies, Inc. (TRV) is profitable, generating $6.29B in net income for the fiscal year ending 2025 with a net profit margin of 12.9%.
The Travelers Companies, Inc. (TRV) reported an operating income of $7.80B, resulting in an operating profit margin of 16.0%. This margin reflects the operational efficiency of the business before interest and taxes.
The Travelers Companies, Inc. (TRV) generated $14.34B in gross profit for the year, representing a gross profit margin of 29.4%. This demonstrates the company's core pricing power and production efficiency.
Key Metrics
Top Statement Risk
Social inflation and cat volatility
Metrics are mathematically derived from official filings.
Growth Decelerates From Double Digits to Flat
TRV's top-line momentum has cooled materially, with quarterly revenue growth sliding from 11.9% in 2024Q3 to -0.5% in 2026Q3, per the company's reported quarterly financials. This reversal suggests hard-market pricing gains are fading as renewal rate increases normalize and exposure growth slows.
The trajectory from consistent high-single to double-digit growth in 2024 to a flat-to-negative print in 2026Q3 appears to reflect the maturation of the hard pricing cycle rather than a demand collapse. For an insurer whose earnings power depends on compounding premium at a rate above loss-cost inflation, a stalling top line narrows the margin for error. Investors should monitor whether subsequent quarters confirm a structural plateau or whether management is deliberately ceding unprofitable business in line with its underwriting-first posture.
Combined Ratio Compression Signals Underwriting Strength
Based on TRV's quarterly disclosures, the combined ratio improved from 94.2% in 2024Q2 to 80.0% in 2026Q3, reflecting sustained underwriting discipline. However, the persistent Q1 spikes suggest catastrophe seasonality remains a structural volatility driver investors should monitor.
The roughly 14-point improvement in the combined ratio over ten quarters implies that pricing actions have more than kept pace with loss-cost inflation, translating into genuine underwriting profit rather than reliance on investment income. Yet the dispersion between the strongest quarter (75.0% in 2025Q4) and the weakest (96.0% in 2025Q1) suggests that a meaningful portion of recent margin strength may be attributable to benign catastrophe experience rather than a permanent structural shift. The underlying combined ratio, stripped of cat losses, would be the cleaner benchmark for assessing durability here.
Loss Ratio Swings Raise Reserve Quality Questions
TRV's loss ratio oscillated between 61.7% and 82.8% across the ten-quarter window, per company financial statements. Such wide dispersion suggests prior-year reserve development and catastrophe timing materially influence reported earnings, warranting investigation into whether recent releases are masking underlying loss trend deterioration.
The 20.9-point swing in loss ratio cannot be explained by intra-year seasonality alone, which implies that changes in estimates for prior-year claims are a significant earnings variable. If the recent benign prints (61.7% in 2025Q4, 63.4% in 2026Q2) are being driven by favorable reserve releases, the current earnings picture may overstate the run-rate quality of underwriting. This is particularly relevant given persistent concerns around social inflation in commercial auto and general liability, where long-tail reserves may not yet fully reflect litigation-cost escalation; future adverse development in these lines would directly pressure the margin gains documented above.
2025 Q1 Catastrophe Shock Frames Recovery
The 2025Q1 trough, where net income fell to $395 million and EPS dropped 64.7% year-over-year on a 96.0% combined ratio, appears to mark a significant inflection point. Subsequent quarters show a strong recovery, suggesting restored pricing and claims discipline.
The 2025Q1 loss, in which claims and loss expenses surged to $9.8B against $11.8B of revenue, stands out as the single most destructive period in the dataset and likely reflects an elevated catastrophe event load or a reserve strengthening action. What matters analytically is the quality of the recovery: from that trough, operating income rebounded to a $2.5–$3.1B quarterly range in 2026, indicating the franchise retained its pricing power rather than losing market share during the shock. However, the fact that 2026Q1 again showed an 82.2% combined ratio versus 76.3% in Q2 suggests the underlying seasonal vulnerability has not been structurally resolved.
Revenue Contraction Undermines Earnings Quality
TRV reported 2026Q3 EPS of $9.04 versus a $7.43 estimate, yet revenue contracted 0.5% year-over-year, per recent SEC filings. This divergence implies the beat may owe more to underwriting margin expansion than top-line momentum, raising questions about forward earnings durability.
The strongest challenge to TRV's reported earnings is the mismatch between an impressive 21.7% EPS beat and a shrinking top line; profitability that is entirely margin-driven is inherently more vulnerable to a single bad catastrophe quarter than profitability anchored in premium growth. Compounding this, the absence of forward guidance alongside the beat introduces uncertainty around whether management views the current combined ratio as sustainable. Furthermore, with investment income data unavailable in the provided dataset, it remains unclear to what extent higher reinvestment yields are subsidizing an underwriting result that may look weaker on a normalized-cat basis than the headline 80.0% suggests.